Marcus T. Ellison

Vice President, Investment Banking

Contact

marcus.ellison@email.com

+1 555 0147

New York, NY

linkedin.com/in/marcusellison-ibkr

Skills

M&A Advisory (Buyside & Sellside)

Leveraged Buyout (LBO) Modeling

Discounted Cash Flow (DCF) Valuation

Equity & Debt Capital Markets

Bloomberg Terminal & Capital IQ

Financial Due Diligence

FINRA Series 79 & Series 63 Licensed

Cross-Border Transaction Structuring

Pitchbook & CIM Authorship

Links

LinkedIn

FINRA Registration

Profile

VP-level investment banker with 9 years of experience executing M&A, leveraged buyouts, and equity capital markets transactions across the technology and healthcare sectors. Closed 34 transactions totaling over $18.2B in aggregate deal value at two bulge-bracket firms. Specialize in cross-border M&A advisory and complex capital structure negotiations for mid-to-large-cap clients.

Work Experience

Vice President, Technology M&A AdvisoryMar 2020 - Present
Hartwell & Crane Securities, New York, NY
  • Led buyside and sellside M&A mandates for 11 technology clients, closing $6.4B in aggregate deal value across SaaS, semiconductor, and enterprise software verticals over four years.
  • Built and stress-tested 40+ integrated DCF, LBO, and precedent-transaction models, reducing model-review cycle time by 35% through a standardized template library adopted firm-wide.
  • Managed a team of 4 analysts and 2 associates on a $1.1B cross-border acquisition of a German cloud-infrastructure firm, coordinating legal, tax, and regulatory workstreams across three jurisdictions and closing on schedule.
Associate, Healthcare Investment BankingJul 2016 - Feb 2020
Meridian Capital Group, New York, NY
  • Executed 14 transactions including 9 M&A deals and 5 equity offerings totaling $4.8B, covering pharmaceutical, medical-device, and health-tech subsectors.
  • Authored 60+ pitch books and confidential information memoranda that supported origination of $920M in new mandates during a single fiscal year.
  • Structured a $340M leveraged recapitalization for a specialty-pharma client, coordinating with six lenders and achieving pricing 45 bps inside initial guidance.
Analyst, Mergers & AcquisitionsJul 2014 - Jun 2016
Meridian Capital Group, New York, NY
  • Supported senior bankers on 9 closed transactions with aggregate value exceeding $3.1B, performing valuation analysis, due-diligence coordination, and buyer/target screening.
  • Built a proprietary comparable-company database covering 280 public healthcare issuers, cutting peer-selection time by 50% across the group.
  • Prepared board-level fairness-opinion materials for a $780M strategic merger, presenting findings directly to the client CFO and outside legal counsel.

Education

B.S. Finance, Minor in Statistics2010 - 2014
University of Virginia — McIntire School of Commerce, Charlottesville, VA
Dean's List all eight semesters; Vice President, Investment Banking Club